The Skin Cancer Center at the University Hospital Basel was founded to offer patients holistic and comprehensive therapy and support for their skin cancer. The University Hospital Basel has a long and successful tradition of diagnosing and treating skin cancer. In addition, the University Hospital Basel also conducts basic and clinical research in the field of skin cancer.


The patient benefits directly from the excellent cooperation of a wide range of specialists who can make a positive contribution to skin cancer patients. In addition to basic care, we also offer patients top-notch medical services.


Our proximity to academia and research guarantees that we stay current on the medical knowledge, and rely on the latest and most effective therapy strategies and international exchange. The regular members of the interdisciplinary conferences are doctors from the fields of dermatology, plastic surgery, vascular surgery, oncology, radiotherapy, nuclear medicine, pathology, genetics and radiology.


The aim of the Skin Cancer Center is to determine the safest and fastest, but also the least burdensome, diagnosis for skin cancer patients in a given constellation.  The holistic therapy is planned in accordance with international guidelines, by agreement of all members of the Skin Cancer Center. Furthermore, we determine the optimal and most sensible cancer follow-up care for patients and identify specific care partners for further support of the patients.


The Skin Cancer Center is constantly updating its knowledge about skin cancer treatment and incorporating new findings directly into the care approach. The expert group also deals with the early detection of all skin cancers and has the appropriate technologies to achieve this goal. The members of the center are also responsible for the continuous training on skin cancer diseases.

Die Patientinnen und Patienten profitieren direkt von der ausgezeichneten Zusammenarbeit verschiedenster Spezialist*innen, welche für Patientinnen und Patienten mit Hauttumoren einen positiven Beitrag leisten können. Das Zentrum bietet den Betroffenen neben der Basisversorgung auch spitzenmedizinische Leistungen an.


Die Nähe zu Lehre und Forschung garantiert den aktuellen Stand des Wissens, die neuesten und wirksamsten Therapiestrategien und einen internationalen Austausch. Ständige Mitglieder der regelmässig stattfindenden interdisziplinären Konferenzen sind Ärztinnen und Ärzte der Fachgebiete Dermatologie, plastische Chirurgie, viszerale Chirurgie, Onkologie, Strahlentherapie, Nuklearmedizin, Pathologie, Genetik und Radiologie.


Das Ziel des Zentrums für Hauttumore ist es, die für Hautkrebspatient*innen sicherste und schnellste, aber auch die am wenigsten belastende Diagnostik in einer gegebenen Konstellation festzulegen. Die ganzheitliche Therapie wird gemäss internationalen Richtlinien, denen alle Mitglieder des Zentrums für Hauttumore zustimmen, geplant.


Weiterhin werden die optimale und sinnvollste Tumornachsorge für die Patientinnen und Patienten festgelegt und die konkreten Betreuungspartner*innen in der weiteren Begleitung der Patientinnen und Patienten bestimmt. Das Zentrum für Hauttumore aktualisiert kontinuierlich das Wissen über die Hautkrebsbehandlung und lässt neue Erkenntnisse unmittelbar in das Betreuungskonzept einfliessen. 

The Skin Cancer Center at the University Hospital Basel offers patients all scientifically documented treatment options that are proven to be effective. In addition to surgical procedures to remove skin tumors and ensure optimum recovery, other modern options are laser and soft X-ray therapies. Radiosurgery and local immune treatments are also part of our range of services. If the patient wishes, we also work with alternative medicine therapists, as long as the respective method can be used together with conventional medicine.


These forms of therapy are particularly suitable for localized tumors. The treatment of facial skin tumors is of particular importance. Patients with advanced skin cancer and metastases often require whole-body therapies with pills or infusions. This chemotherapy is carried out by cancer specialists (oncologists). In the case of melanoma, groundbreaking new chemotherapy options have been introduced in recent years and are being administered by our oncologists. Modern radiotherapy with all the techniques is another pillar for patients with extensive and advanced skin cancers.


The decision as to which type of therapy should be carried out in patients with complex skin cancers is made at an interdisciplinary cancer conference with all specialists.


Dermato-Oncology SOP: Melanoma, actinic keratosis, squamous cell carcinoma, basal cell carcinoma, Merkel cell carcinoma

We provide you with expert advice on the treatment of your skin diseases and the possible side effects. Skin disease prevention is also a key topic for us.


We would be happy to advise you on:


  • Sun protection
  • Compression therapy
  • Wound healing, especially for chronic wounds
  • Outpatient wound care


Skin cancers can lead to unpleasant and painful wounds that have a negative impact on everyday life. Our wound experts support patients and their families with the aim of wound treatment without complications.


Felix Rothmann
Zentrum für Hauttumore
Universitätsspital Basel
Petersgraben 4
4031 Basel

Tel. +41 61 328 47 32



Prof. Dr. med. Dr. sc. nat. Alexander Navarini



Leiter Zentrum für Hauttumore, Ärztliche Co-Leitung Klinische Forschung


Prof. Dr. Dirk Johannes Schaefer

Chefarzt Plastische, Rekonstruktive, Ästhetische Chirurgie und Handchirurgie

Ärztlicher Departementsleiter

Stv. Leiter Zentrum für Hauttumore, Departement Muskuloskelettales System



Dr. Anne-Katharina Sonntag





Prof. Daniel Boll

Stv. Chefarzt Radiologie und Nuklearmedizin

Leitung abdominelle und onkologische Diagnostik, med. Dienstleistung


Prof. Dr. rer. nat. Sven Cichon


Medizinische Genetik


Sabrina Elia, M.Sc.



Show profile


Prof. Katharina Glatz

Leitende Ärztin


Mitglied Tumorzentrum, Dermatopathologie, Herz-/Gefässpathologie, Endokrinopathologie, Gynäko- und Mammapathologie, Gastrointestinale Pathologie, Autopsie, Lehre


PD Dr. Markus Gross

Stv. Chefarzt


Stv. Leiter Gynäkologisches Tumorzentrum, Stv. Leiter Hirntumorzentrum

Show profile


Christina Klanke Mag. art., MPH

Departementsfachleitung Pflege/MTT

Departement Theragnostik


Prof. Alfred Zippelius


Medizinische Onkologie FMH, Mitglied Tumorzentrum, Leiter Labor Tumorimmunologie

Hauttumore, Thoraxtumore, Immuntherapie

Show profile